JCO Precision Oncology
Exploring the Melanoma and Pancreatic Cancer Phenotype of a Potential CDKN2A Founder Variant, I49T (c.146T>C; p.Ile49Thr), in Individuals of Predominantly Mexican Ancestry
Study in peoplePopulations
The paper
University of Southern California
JCO Precision Oncology, 17 Sep 2026

